# Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

> **NCT00553423** · PHASE3 · UNKNOWN · sponsor: **Aga Khan University** · enrollment: 128 (estimated)

## Conditions studied

- Hepatocerebral Encephalopathy
- Portal-Systemic Encephalopathy
- Encephalopathy, Hepatic
- Encephalopathy, Hepatocerebral

## Interventions

- **DRUG:** Lactulose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00553423
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2007-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553423, "Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00553423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*